QUOTE AND NEWS
Market Intelligence Center  Mar 19  Comment 
The patented options-trade picking algorithms used by MarketIntelligenceCenter.com found a trading opportunity with Meritage Homes Corp (MTH) that should provide a 9.14% return in just 92 days. Sell one Jun. '15 call at the $45.00 level for each...
GenEng News  Feb 24  Comment 
Shire has acquired Meritage Pharma for up-to-$245 million, in a deal that further strengthens the biotech giant’s gastrointestinal (GI) and rare disease portfolios with a Phase III-ready treatment—namely the acquired company’s Oral...
FierceBiotech  Feb 24  Comment 
Fresh from completing a $5 billion deal for NPS Pharma, Shire stopped to bag a small San Diego biotech, picking up Meritage Pharma and a Phase III-ready rare disease drug for $70 million upfront and a slate of unspecified milestones.
Market Intelligence Center  Feb 19  Comment 
Meritage Homes Corp (MTH) closed Wednesday at $42.82 and technical indicators recently have been bullish. Based in part on those numbers, MarketIntelligenceCenter.com's patented algorithms have identified a couple of attractive trading...
Market Intelligence Center  Feb 13  Comment 
MarketIntelligenceCenter.com’s patented algorithms have chosen the Jun. '15 $40.00 call for a couple of hedged-trading ideas on Meritage Homes Corp (MTH). A traditional covered call on Meritage Homes yields 6.02% (17.43% annualized, for...
TheStreet.com  Feb 10  Comment 
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.  TheStreet Ratings quantitative algorithm...
Market Intelligence Center  Feb 2  Comment 
MarketIntelligenceCenter.com’s patented option-trade picking algorithm found two trade ideas on Meritage Homes Corp (MTH) today after it traded between between $35.38 and $36.59 before closing at $36.41 on Friday. For more conservative...





You may also be interested in articles related to Meritage (MTH):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki